Article
Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
Journal of medical virology - 1 Jan 2023
Rosário Andreia, Sousa Ana, Marinho-Dias Joana, Medeiros Rui, Lobo Cláudia, Leça Luís, Coimbra Nuno, Tavares Fernando, Baldaque Inês, Martins Gabriela, Monteiro Paula, Henrique Rui, Sousa Hugo
Abstract excerpt
Cervical cancer prevention is based on primary prevention with vaccines against Human Papillomavirus (HPV) and secondary prevention by screening with High-Risk-HPV (Hr-HPV) detection. Since 2017, cervical cancer screening in women aged 25-60 years has been performed in Portugal using Hr-HPV detection, followed by cytology in Hr-HPV-positive cases. Herein we report the prevalence of Hr-HPV genotypes and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.